Cigna Group (NYSE:CI - Get Free Report) had its price target upped by Royal Bank Of Canada from $337.00 to $346.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has an "outperform" rating on the health services provider's stock. Royal Bank Of Canada's target price points to a potential upside of 26.03% from the stock's current price.
Other research analysts also recently issued research reports about the company. Wells Fargo & Company lifted their price objective on Cigna Group from $307.00 to $325.00 and gave the stock an "equal weight" rating in a report on Friday, November 13th. Evercore assumed coverage on Cigna Group in a report on Wednesday, September 9th. They set an "in-line" rating and a $290.00 target price for the company. Barclays increased their target price on Cigna Group from $310.00 to $320.00 and gave the company an "equal weight" rating in a report on Monday, November 9th. Wall Street Zen upgraded Cigna Group from a "hold" rating to a "buy" rating in a research report on Sunday, November 8th. Finally, Jefferies Financial Group lifted their price target on Cigna Group from $288.00 to $304.00 and gave the stock a "hold" rating in a research note on Thursday, November 12th. Fourteen equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company's stock. According to data from MarketBeat, Cigna Group currently has a consensus rating of "Moderate Buy" and an average price target of $337.35.
View Our Latest Research Report on Cigna Group
Cigna Group Trading Down 3.8%
Shares of CI traded down $10.83 during mid-day trading on Thursday, reaching $274.54. The company's stock had a trading volume of 262,879 shares, compared to its average volume of 1,667,334. The stock has a market cap of $72.34 billion, a PE ratio of 12.18, a P/E/G ratio of 1.10 and a beta of 0.25. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.66. Cigna Group has a 52 week low of $257.85 and a 52 week high of $318.05. The company's fifty day moving average price is $288.37 and its two-hundred day moving average price is $283.00.
Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The health services provider reported $7.98 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.52 by $0.46. The company had revenue of $73.79 billion during the quarter, compared to analysts' expectations of $72.64 billion. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. The firm's revenue was up 5.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $7.83 EPS. On average, analysts predict that Cigna Group will post 30.71 earnings per share for the current fiscal year.
Insider Buying and Selling at Cigna Group
In other news, insider Everett Neville sold 617 shares of the stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the sale, the insider directly owned 5,053 shares in the company, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company's stock.
Institutional Investors Weigh In On Cigna Group
Several institutional investors and hedge funds have recently bought and sold shares of CI. Osbon Capital Management LLC bought a new position in shares of Cigna Group during the second quarter valued at approximately $26,000. Putney Financial Group LLC bought a new stake in Cigna Group in the third quarter valued at $27,000. Johnson Financial Group Inc. purchased a new position in Cigna Group during the 2nd quarter valued at $29,000. Fiduciary Financial Advisors purchased a new position in Cigna Group during the 2nd quarter valued at $29,000. Finally, ANTIPODES PARTNERS Ltd purchased a new position in Cigna Group during the 2nd quarter valued at $34,000. Hedge funds and other institutional investors own 86.99% of the company's stock.
About Cigna Group
(
Get Free Report)
The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.